1 results
Ursula Wiedermann, Karl Zwiauer, Michael Kundi, Angelika Wagner
AIM: The four-component meningococcal serogroup B (4CMenB) vaccine was licensed by the European Medicines Agency in 2013. We evaluated current practice regarding multiple vaccines and the attitudes...